Bellerophon Therapeutics, Inc.·4

Feb 14, 4:47 PM ET

Shah Parag Suresh 4

4 · Bellerophon Therapeutics, Inc. · Filed Feb 14, 2023

Insider Transaction Report

Form 4
Period: 2023-02-10
Shah Parag Suresh
VP Proj Mgmt & Distribution
Transactions
  • Award

    Stock Options (right to buy)

    2023-02-10$1.52/sh+50,000$76,00050,000 total
    Exercise: $1.52Exp: 2033-02-10Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]This option vests as to 25% of the underlying shares on February 10, 2024 and the remaining options vest quarterly over a period of 3 years thereafter.

Documents

1 file
  • 4
    form4-02142023_040211.xmlPrimary